HeLa Cell Nuclear Extract Doxorubicin Stimulated

Produktübersicht

• Artikelname: HeLa Cell Nuclear Extract Doxorubicin Stimulated
• Artikelnummer: ROC-W09-001-A82
• Hersteller Artikelnummer: W09-001-A82
• Alternativnummer: ROC-W09-001-A82
• Hersteller: Rockland Immunochemicals
• Kategorie: Zellen/Zellkultur
• Applikation: SDS-PAGE
• Konjugation: Unconjugated
• Alternative Synonym: HeLa Cell Nuclear Extract Doxorubicin Stimulated, HeLa Nuclear Lysate Doxorubicin Stimulated, HeLa Doxorubicin Stimulated Nuclear Extract, HeLa Doxorubicin Stimulated Nuclear Lysate

Produkteigenschaften

• Konzentration: 1.0 mg/mL by BCA assay
• Puffer: 1X SDS-PAGE Sample Buffer (62.5 mM Tris HCl, 2% SDS, 10% Glycerol and 0.005% bromophenol blue, pH 6.8)
• Quelle: Human
• Formulierung: Liquid (sterile filtered)

Anwendungsbeschreibung

• Application Verdünnung: WB: User Optimized
• Anwendungsbeschreibung: W09-001-A82 has been tested by SDS-PAGE. Ready-to-use nuclear extracts are especially prepared as positive controls for separation by SDS-PAGE and subsequent western blot analysis. Nuclear extracts are supplied in denaturing buffer without dissociating a

Bilder

Coomassie stained SDS-PAGE of 25 ?g of Doxorubicin stimulated Human Derived Hela Cell Nuclear Extract (Ready-to-Use) separated in a 4-20% gradient gel under non-reducing conditions. Molecular weight standards are shown on the left.